Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Manukai | 2025 | Grant | Undisclosed | Zürich |
| Apheros | 2025 | Grant | Undisclosed | Zürich |
| Isochronic | 2025 | Grant | Undisclosed | Vaud |
| Mabylon | 2025 | Undisclosed | $18.6M | Schlieren |
| Azure Cell Therapies | 2025 | Grant | $189K | Geneva |
| Nutrix | 2025 | Grant | $78K | Basel |
| Biosimo | 2025 | Grant | $300K | Zürich |
| Cryowrite | 2025 | Grant | $1.9M | Basel |
| Aldena Therapeutics | 2025 | Grant | $656K | Boston |
| Positrigo | 2025 | Series Unknown | $8.5M | Zürich |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 151 | Manukai | Grant | Undisclosed | Zürich, Switzerland |
| 152 | Apheros | Grant | Undisclosed | Zürich, Switzerland |
| 153 | Isochronic | Grant | Undisclosed | Vaud, Switzerland |
| 154 | Mabylon | Undisclosed | $18.6M | Schlieren, Switzerland |
| 155 | Azure Cell Therapies | Grant | $189K | Geneva, Switzerland |
| 156 | Nutrix | Grant | $78K | Basel, Switzerland |
| 157 | Biosimo | Grant | $300K | Zürich, Switzerland |
| 158 | Cryowrite | Grant | $1.9M | Basel, Switzerland |
| 159 | Aldena Therapeutics | Grant | $656K | Boston, United States |
| 160 | Positrigo | Series Unknown | $8.5M | Zürich, Switzerland |
Manukai, an ETH Zurich spin-off, creates novel AI models to unlock the value of production data in metal machining.
Apheros is a metal foam cooling solutions company that offers a patent-pending easily scalable manufacturing approach for metal foams.
Isochronic manufactures industrial robotic products for pick and place applications by transporting multiple parts simultaneously.
Mabylon develops novel antibody therapeutics in immunology & inflammation (I&I) and neurological disorders.
Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases
High-Impact Preventive Healthcare That Works
Biosimo Chemicals produces sustainable chemicals
Cryowrite is a sample preparation for cryo-electron microscopy.
Aldena Therapeutics is a private biotech startup that invented siRNA-based treatments for dermatological conditions.
Positrigo is a company dedicated to the development, production, and sales of dedicated brain positron emission tomography (PET) scanners.
Wildbiene + Partner contributes to a balanced ecosystem by providing sustainable pollination and high-quality bee experiences.
KOMP-ACT develops innovative electric motion technology for the industrial automation industry for a carbon-neutral future.
Adoram Therapeutics is a company that uses the benefits of allosteric biochemistry to develop novel therapies.
OncoSwab is creating a point-of-care test to detect lung cancer in high-risk individuals.
MPower Ventures is a technology company that offers funding, software, and solar products to facilitate energy access in emerging markets.
Pace Locator device generates 3D maps of cardiac signal origin using ECG and ECHO data.
Akina provides AI-enabled connected therapy for patients with musculoskeletal conditions.
Capt'n Greenfin is a new material for sustainable fishing baits and aims to revolutionize the sportfishing industry in a sustainable way.
Vestir AI is a retail tech company that offers a platform for online clothes shopping through AI-powered digital avatar technology.
Ymmunobio is a preclinical-stage oncology biotech startup committed to creating advanced cancer patient treatments.
Vatorex enhances honey bee health through an effective and practicable hyperthermic system to fight the varroa mite.
Geospatial ML SaaS platform for Earth Observation imagery
Bionomous automates the screening, sorting, and plating of miniature biological entities to accelerating science
Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders.
ASPIVIX is developing a device that makes gynecological procedures more comfortable for patients.
Innosuisse has invested in 211 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Innosuisse's top investment sectors include Biotechnology, Manufacturing, Health Care, Medical, Machine Learning. The firm invests across 41 different industry categories.
Among tracked funding rounds, Mabylon received $18.6M in a Undisclosed round. Innosuisse's total known invested capital is $569.8M.
Innosuisse's average investment size is $3.2M across its portfolio of 211 companies.
Recent Innosuisse portfolio additions include Manukai, Apheros, Isochronic, Mabylon, Azure Cell Therapies. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors